We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

I’ve been PCMag’s home entertainment expert for over 10 years, covering both TVs and everything you might want to connect to them. I’ve reviewed more than a thousand different consumer ...

When I lived in a smaller apartment, I didn’t put much thought into hanging up family photos, mostly because I didn’t have the wall space. Once I moved into a larger home, though, the art I ...

To find the best cloud storage options for photos, we look for services that make uploading and organizing images effortless, while providing ample storage space at an affordable price.

Buy or sell stocks: Riyank Arora of Mehta Equities recommends short selling Ipca Laboratories Ltd, Sun Pharmaceutical Industries Ltd, and H.G. Infra Engineering Ltd. Torrent Pharma announced an in ...

Selatogrel is under clinical development by Idorsia Pharmaceutical and currently in Phase III for ... Idorsia’s pipeline includes various drugs for the treatment of fabry disease, pediatric insomnia, ...

Freezing cold temperatures saw the traditionally outdoors event forced inside and held in the rotunda of the US Capitol. In his inauguration speech, Mr Trump declared "the golden age of America ...

Donald Trump is now the 47th president of the United States, as well as the 45th president, a businessman - and a man who knows how to put on a show. Former presidents, Trump family members, tech ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.